NEUTRISCI INTERNATIONAL INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 CAD | 0.00% |
|
0.00% | 0.00% |
| 2023 | NeutriSci International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
| 2023 | NeutriSci International Inc. Announces Board of Director Changes | CI |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 24.54 | 9.17 | 3.017 | 19.5 | 9.137 | 2.639 |
| Enterprise Value (EV) 1 | 24.23 | 8.895 | 3.063 | 19.49 | 9.166 | 2.643 |
| P/E ratio | -10.2 x | -3.41 x | -1.8 x | -9.55 x | -5.55 x | -3.23 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 162 x | 111 x | 31.3 x | 261 x | 113 x | 5.77 x |
| EV / Revenue | 160 x | 108 x | 31.7 x | 261 x | 113 x | 5.77 x |
| EV / EBITDA | -11.6 x | -3.78 x | -1.86 x | -10.2 x | -6.29 x | -3.7 x |
| EV / FCF | -31 x | -7.55 x | -4.63 x | -24.9 x | -14.7 x | 21 x |
| FCF Yield | -3.22% | -13.2% | -21.6% | -4.02% | -6.8% | 4.77% |
| Price to Book | 187 x | 31.6 x | -19.3 x | -216 x | -192 x | -4.28 x |
| Nbr of stocks (in thousands) | 92,612 | 114,630 | 120,699 | 149,997 | 166,124 | 175,963 |
| Reference price 2 | 0.2650 | 0.0800 | 0.0250 | 0.1300 | 0.0550 | 0.0150 |
| Announcement Date | 4/27/18 | 4/29/19 | 4/27/20 | 4/29/21 | 5/2/22 | 5/1/23 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.1511 | 0.0827 | 0.0965 | 0.0746 | 0.0809 | 0.4578 |
| EBITDA 1 | -2.083 | -2.355 | -1.645 | -1.917 | -1.458 | -0.7133 |
| EBIT 1 | -2.093 | -2.375 | -1.65 | -1.944 | -1.503 | -0.7506 |
| Operating Margin | -1,385.6% | -2,873.2% | -1,708.73% | -2,607.17% | -1,857.63% | -163.97% |
| Earnings before Tax (EBT) 1 | -2.122 | -2.383 | -1.613 | -1.953 | -1.572 | -0.7707 |
| Net income 1 | -2.122 | -2.383 | -1.613 | -1.953 | -1.572 | -0.7707 |
| Net margin | -1,404.81% | -2,882.67% | -1,670.71% | -2,618.34% | -1,943.53% | -168.37% |
| EPS 2 | -0.0259 | -0.0234 | -0.0139 | -0.0136 | -0.009913 | -0.004638 |
| Free Cash Flow 1 | -0.7813 | -1.178 | -0.661 | -0.7844 | -0.6233 | 0.126 |
| FCF margin | -517.17% | -1,424.79% | -684.66% | -1,051.81% | -770.52% | 27.52% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/27/18 | 4/29/19 | 4/27/20 | 4/29/21 | 5/2/22 | 5/1/23 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 0.05 | - | 0.03 | 0 |
| Net Cash position 1 | 0.31 | 0.28 | - | 0.01 | - | - |
| Leverage (Debt/EBITDA) | - | - | -0.0278 x | - | -0.0201 x | -0.004709 x |
| Free Cash Flow 1 | -0.78 | -1.18 | -0.66 | -0.78 | -0.62 | 0.13 |
| ROE (net income / shareholders' equity) | -533% | -1,170% | -2,698% | 1,584% | 2,281% | 232% |
| ROA (Net income/ Total Assets) | -150% | -257% | -195% | -235% | -139% | -81.5% |
| Assets 1 | 1.412 | 0.9268 | 0.8278 | 0.83 | 1.128 | 0.9454 |
| Book Value Per Share 2 | 0 | 0 | -0 | -0 | -0 | -0 |
| Cash Flow per Share 2 | 0 | 0 | - | 0 | 0 | 0 |
| Capex | - | 0.03 | - | 0.11 | 0.11 | 0 |
| Capex / Sales | - | 34.1% | - | 148.15% | 132.8% | 1.04% |
| Announcement Date | 4/27/18 | 4/29/19 | 4/27/20 | 4/29/21 | 5/2/22 | 5/1/23 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 652K | |
| +8.20% | 7.78B | |
| +0.34% | 7.38B | |
| +10.20% | 6.52B | |
| -8.10% | 3.67B | |
| -14.57% | 1.17B | |
| +8.34% | 934M | |
| -42.27% | 879M | |
| -18.90% | 836M | |
| -16.45% | 802M |
- Stock Market
- Equities
- NU Stock
- Financials NeutriSci International Inc.
